Clarity secures IND from FDA for radiotracer for prostate cancer

Clarity Pharmaceuticals has secured investigational new drug approval (IND...Read more on AuntMinnie.comRelated Reading: Clarity treats first patient in COBRA trial Clarity launching trial for prostate cancer therapy Clarity hits milestone in study of radiopharmaceutical NorthStar partners with Clarity, Monopar FDA grants rare disease designation to Clarity agent
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news